Symbol="GERN"
AssetType="Common Stock"
Name="Geron Corporation"
Description="Geron Corporation, an advanced stage clinical biopharmaceutical company, focuses on the development and commercialization of therapies for myeloid hematologic neoplasms. The company is headquartered in Foster City, California."
CIK="886744"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="149 COMMONWEALTH DRIVE, SUITE 2070, MENLO PARK, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1536476000"
EBITDA="-173563008"
PERatio="None"
PEGRatio="-2.38"
BookValue="0.572"
DividendPerShare="0"
DividendYield="0"
EPS="-0.36"
RevenuePerShareTTM="0.001"
ProfitMargin="0"
OperatingMarginTTM="-386.54"
ReturnOnAssetsTTM="-0.333"
ReturnOnEquityTTM="-0.777"
RevenueTTM="450000"
GrossProfitTTM="-93668000"
DilutedEPSTTM="-0.36"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.603"
AnalystTargetPrice="4.83"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="571.98"
PriceToBookRatio="8.28"
EVToRevenue="493.55"
EVToEBITDA="-6.08"
Beta="0.859"
num_52WeekHigh="3.84"
num_52WeekLow="1.95"
num_50DayMovingAverage="3.2"
num_200DayMovingAverage="2.732"
SharesOutstanding="508767000"
DividendDate="None"
ExDividendDate="None"
symbol="GERN"
open="3.01"
high="3.10"
low="2.98"
price="3.01"
volume="3905926.00"
latest_trading_day="2023-08-10"
previous_close="3.02"
change="-0.01"
change_percent="-0.3311%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="31"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="69"
Volume_recent_avg="5544670"
Change_recent_avg="0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="69"
Aroon_momentum_negative="31"
image_negative_thumbnail_id_1="489"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0116.jpeg"
image_negative_thumbnail_id_2="140"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0036.jpeg"
image_neutral_thumbnail_id_1="550"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_neutral_thumbnail_id_2="531"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0068.jpeg"
image_positive_thumbnail_id_1="975"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_positive_thumbnail_id_2="701"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0007.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
